324 related articles for article (PubMed ID: 31733291)
1. Noncoding RNAs as potential mediators of resistance to cancer immunotherapy.
Vishnubalaji R; Shaath H; Elango R; Alajez NM
Semin Cancer Biol; 2020 Oct; 65():65-79. PubMed ID: 31733291
[TBL] [Abstract][Full Text] [Related]
2. Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeutics.
Smolle MA; Calin HN; Pichler M; Calin GA
FEBS J; 2017 Jul; 284(13):1952-1966. PubMed ID: 28132417
[TBL] [Abstract][Full Text] [Related]
3. Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression.
Saleh R; Elkord E
Semin Cancer Biol; 2020 Oct; 65():13-27. PubMed ID: 31362073
[TBL] [Abstract][Full Text] [Related]
4. Noncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application.
Zhang L; Xu X; Su X
Mol Cancer; 2020 Mar; 19(1):48. PubMed ID: 32122338
[TBL] [Abstract][Full Text] [Related]
5. Noncoding RNAs as novel immunotherapeutic tools against cancer.
Kaur M; Kaur B; Konar M; Sharma S
Adv Protein Chem Struct Biol; 2022; 129():135-161. PubMed ID: 35305717
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory MicroRNAs in cancer: targeting immune checkpoints and the tumor microenvironment.
Omar HA; El-Serafi AT; Hersi F; Arafa EA; Zaher DM; Madkour M; Arab HH; Tolba MF
FEBS J; 2019 Sep; 286(18):3540-3557. PubMed ID: 31306553
[TBL] [Abstract][Full Text] [Related]
7. Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential.
Pi YN; Qi WC; Xia BR; Lou G; Jin WL
Front Immunol; 2021; 12():697083. PubMed ID: 34295338
[TBL] [Abstract][Full Text] [Related]
8. miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy.
Di Martino MT; Riillo C; Scionti F; Grillone K; Polerà N; Caracciolo D; Arbitrio M; Tagliaferri P; Tassone P
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33808190
[TBL] [Abstract][Full Text] [Related]
9. Non-coding RNA and immune-checkpoint inhibitors: friends or foes?
Shek D; Read SA; Akhuba L; Qiao L; Gao B; Nagrial A; Carlino MS; Ahlenstiel G
Immunotherapy; 2020 May; 12(7):513-529. PubMed ID: 32378480
[TBL] [Abstract][Full Text] [Related]
10. Non-coding RNA in tumor-infiltrating regulatory T cells formation and associated immunotherapy.
Ma Y; Xu X; Wang H; Liu Y; Piao H
Front Immunol; 2023; 14():1228331. PubMed ID: 37671150
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNAs in cancer-immunity cycle.
Yu WD; Wang H; He QF; Xu Y; Wang XC
J Cell Physiol; 2018 Sep; 233(9):6518-6523. PubMed ID: 29574911
[TBL] [Abstract][Full Text] [Related]
12. Overcoming immunotherapeutic resistance by targeting the cancer inflammation cycle.
Wattenberg MM; Beatty GL
Semin Cancer Biol; 2020 Oct; 65():38-50. PubMed ID: 31954172
[TBL] [Abstract][Full Text] [Related]
13. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
[TBL] [Abstract][Full Text] [Related]
14. Noncoding RNAs: the shot callers in tumor immune escape.
Liu L; Wang Q; Qiu Z; Kang Y; Liu J; Ning S; Yin Y; Pang D; Xu S
Signal Transduct Target Ther; 2020 Jun; 5(1):102. PubMed ID: 32561709
[TBL] [Abstract][Full Text] [Related]
15. The Potential Role of circRNA in Tumor Immunity Regulation and Immunotherapy.
Xu Z; Li P; Fan L; Wu M
Front Immunol; 2018; 9():9. PubMed ID: 29403493
[TBL] [Abstract][Full Text] [Related]
16. Noncoding RNAs as an emerging resistance mechanism to immunotherapies in cancer: basic evidence and therapeutic implications.
Wang M; Yu F; Li P
Front Immunol; 2023; 14():1268745. PubMed ID: 37767098
[TBL] [Abstract][Full Text] [Related]
17. Tackling Resistance to Cancer Immunotherapy: What Do We Know?
Gondhowiardjo SA; Handoko ; Jayalie VF; Apriantoni R; Barata AR; Senoaji F; Utami IJW; Maubere F; Nuryadi E; Giselvania A
Molecules; 2020 Sep; 25(18):. PubMed ID: 32911646
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects.
Jia H; Truica CI; Wang B; Wang Y; Ren X; Harvey HA; Song J; Yang JM
Drug Resist Updat; 2017 May; 32():1-15. PubMed ID: 29145974
[TBL] [Abstract][Full Text] [Related]
19. Current concepts of non-coding RNA regulation of immune checkpoints in cancer.
Smolle MA; Prinz F; Calin GA; Pichler M
Mol Aspects Med; 2019 Dec; 70():117-126. PubMed ID: 31582259
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA: a dazzling dancer in tumor immune microenvironment.
Zhang Y; Liu Q; Liao Q
J Exp Clin Cancer Res; 2020 Nov; 39(1):231. PubMed ID: 33148302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
